GregFolin

$RXMD Springs Off Key Support into Major Telehealth Acquisition

Long
OTC:RXMD   Progressive Care, Inc.
RXMD retesting key support on a strong price flush to shake out weak hands. This comes as the company acquires a leading Telehealth platform and readies to expand its operational reach to all 50 US states (from 14) while on pace to record a projected $50 million in 2020 revenues.

Progressive Care Inc. (OTCMKTS:RXMD) is making moves that place it at the heart of the Telehealth shift, especially with its recent move to acquire MyApps, which is the sole owner of the popular telehealth service, app CallingDr™ (www.callingdr.com).

CallingDr™ is a fully-launched virtual platform providing multiple levels of service with a suite of products, including the capability to allow patients to take ownership of their own health records and provide access to health information through the related app and patient portal.

The reach already includes hundreds of medical practices in multiple states, including gastrointestinal, internal medicine, psychiatry, pulmonology, cardiology as well as remote clinics and in-patient settings. Customers include single-physician clinics, multi-physician clinics, emergency room centers, nursing homes, and home health setups.

CallingDr™ was ranked in the top ten list of patient engagement solution providers by Healthcare Tech Magazine in 2019, it’s already been integrated into top connected medical devices such as Thinklab’s Stethoscopes, it has already gotten into big systems like PointClickCare, the leading cloud-based Electronic Health Record (EHR) software designed specifically for the long-term care providers system, and it has accolades, including Technology Innovators, a leading tech-based digital publication, which listed CallingDr™ as one of the top 20 Innovators in Telemedicine for 2020.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.